Synthesis, method optimization, anticancer activity of 2,3,7-trisubstituted Quinazoline derivatives and targeting EGFR-tyrosine kinase by rational approach-Reference-Cited by-同舟云学术

Synthesis, method optimization, anticancer activity of 2,3,7-trisubstituted Quinazoline derivatives and targeting EGFR-tyrosine kinase by rational approach

Published:2013-01 Issue:1 Volume:6 Page:35-48
ISSN:1878-5352
Container-title:Arabian Journal of Chemistry
language:en
Short-container-title:Arabian Journal of Chemistry

Author:

Noolvi Malleshappa N.,Patel Harun M.

Funder

Director General, Department of Science and Technology, New Delhi

Publisher

Elsevier BV

Subject

General Chemical Engineering,General Chemistry

Reference20 articles.

1. Kinetic and catalytic mechanisms of protein kinases;Adams;Chem. Rev.,2001

2. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay;Alley;Cancer Res.,1988

3. QSAR study of Benzthiazole derivatives as p56 lck inhibitors;Badiger;Lett. Drug Des. Discov.,2006

4. Oncogenic kinase signaling;Blume-Jensen;Nature,2001

5. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen;Boyd;Drug Dev. Res.,1995

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of 8-methyl-2-phenylquinazolin-4(3H)-ones derived Schiff's bases: Spectroscopic properties, SAR, docking approaches and their anticancer and antimicrobial activity;Journal of Molecular Structure;2024-08

2. Design and synthesis of quinazolin-4-one derivatives as potential anticancer agents and investigation of their interaction with RecQ helicases;Bioorganic Chemistry;2024-03

3. Compounds Consisting of Quinazoline, Ibuprofen, and Amino Acids with Cytotoxic and Anti‐Inflammatory Effects;ChemMedChem;2024-02-28

4. Anti-colorectal Cancer Activity of Quinazoline Derivatives: A Comprehensive Review;Letters in Drug Design & Discovery;2023-03-10

5. In-silico, synthesis, structure elucidation and anticancer activity study of 2-(3,4-dichlorophenyl)-4H-benzo[d][1,3]oxazin-4-one;PAK J PHARM SCI;2022